Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | DRD1 | P21728 | 3/20 | 0.39 |
| ▸ | DRD5 | P21918 | 3/20 | 0.39 |
| ▸ | ALOX5AP | P20292 | 4/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | GPR3 | P46089 | 1/20 | 0.38 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23051242 | 0.95 | KDM4E (0.48) | KDM4EATML3MBTL1PTGS2PTPN1 | |
| SCHEMBL13290123 | 0.92 | KDM4E (0.46) | KDM4EATML3MBTL1PTGS2PTPN1 | |
| SCHEMBL13562910 | 0.90 | PTGS2 (0.48) | KDM4EATML3MBTL1PTGS2PTPN1 | |
| SCHEMBL20710251 | 0.85 | KDM4E (0.55) | KDM4EATML3MBTL1PTGS2PTPN1 | |
| SCHEMBL24432179 | 0.85 | KDM4E (0.55) | KDM4EATML3MBTL1PTGS2PTPN1 | |
| SCHEMBL12110621 | 0.85 | KDM4E (0.48) | KDM4EATML3MBTL1PTGS2PTPN1 | |
| SCHEMBL19762215 | 0.85 | KDM4E (0.46) | KDM4EATML3MBTL1PTGS2PTPN1 | |
| SCHEMBL10111049 | 0.85 | HPGD (0.45) | KDM4EATML3MBTL1PTGS2PTPN1 | |
| SCHEMBL14849963 | 0.83 | KDM4E (0.50) | KDM4EATML3MBTL1PTGS2PTPN1 | |
| SCHEMBL262011 | 0.83 | PTPN1 (0.41) | KDM4EATML3MBTL1PTGS2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230247898-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
| US-11653562-B2 | Organic electroluminescent compound and organic electroluminescent device comprising the same | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. | 2023-05-16 | — | — | US | disclosed |
| US-20220173330-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2022-06-02 | — | — | US | disclosed |
| US-20220045281-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) | 2022-02-10 | — | — | US | disclosed |
| US-20210320252-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2021-10-14 | — | — | US | disclosed |
| US-20210320263-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220045281-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ELAVL1, ICOSLG, OR10J3 | KDM4E 1059/4885ATM 2282/4885L3MBTL1 110/4885 |
| US-11653562-B2 | Organic electroluminescent compound and organic electroluminescent device comprising the same | OPA1, ODC1, TMEM109 | KDM4E 1399/4885ATM 2518/4885L3MBTL1 413/4885 |
| US-20220173330-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | LEF1, ODC1, OR10J3 | KDM4E 1293/4885ATM 2614/4885L3MBTL1 772/4885 |
| US-20210320252-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | OPA1, ODC1, TMEM109 | KDM4E 1399/4885ATM 2518/4885L3MBTL1 413/4885 |
| US-20230247898-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | OPA1, ODC1, TMEM109 | KDM4E 1399/4885ATM 2518/4885L3MBTL1 413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.